Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseTissue DonorsWhole-Body IrradiationKidney TransplantationTransplantation, AutologousLeukemiaAnemia, AplasticGraft SurvivalHematopoietic Stem Cell TransplantationCytomegalovirus InfectionsImmunosuppressive AgentsHistocompatibility TestingGraft RejectionTransplantation ConditioningImmunosuppressionTransplantsHematopoietic Stem CellsHematologic NeoplasmsHistocompatibilityCyclosporineImmunocompromised HostOpportunistic InfectionsTime FactorsTreatment OutcomeBone Marrow PurgingBone Marrow DiseasesRetrospective StudiesLeukemia, Myeloid, AcuteTransplantationRecurrenceBone Marrow ExaminationTransplantation ChimeraCytomegalovirusLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMycosesPneumonia, ViralPrecursor Cell Lymphoblastic Leukemia-LymphomaHematopoiesisHeart TransplantationBone Marrow NeoplasmsAcute DiseaseBusulfanSurvival AnalysisGanciclovirHLA AntigensTransplantation, IsogeneicMice, Inbred C57BLAntilymphocyte SerumRadiation ChimeraFatal OutcomeColony-Forming Units AssayGraft vs Host ReactionCyclophosphamideLymphocyte DepletionHematologic DiseasesPostoperative ComplicationsLung TransplantationCombined Modality TherapyMyelodysplastic SyndromesHepatic Veno-Occlusive DiseaseLiving DonorsNuclear FamilyAspergillosisCystitisT-LymphocytesSurvival RateBlood Group IncompatibilityLeukemia, MyeloidTacrolimusTransplantation ImmunologyFollow-Up StudiesLymphoma, Non-HodgkinBK VirusDisease-Free SurvivalPolymerase Chain ReactionInfectionMucormycosisTissue and Organ ProcurementLeukocyte CountLymphocyte TransfusionRemission InductionRisk FactorsCyclosporinsAntiviral AgentsChimeraCell DifferentiationSpleenAntigens, CD34Flow CytometryAntifungal AgentsHerpesvirus 6, HumanHodgkin DiseasePeripheral Blood Stem Cell TransplantationProspective StudiesLeukocyte TransfusionActuarial Analysis